Abstract
Herpes zoster infections are frequently observed after allogeneic bone marrow transplantation (alloBMT). In the majority of cases, the infection is restricted to specific dermatomes and responds to oral acyclovir, without visceral dissemination. We report the case of a 40-year-old male who developed dermatomal herpetic infection 8 months post alloBMT. The herpetic rash responded well to treatment with high-dose oral acyclovir. However, within a week of cessation of therapy, the patient re-presented with dermatomal zoster and meningoencephalitis. Although the cutaneous lesions resolved with intravenous acyclovir, clinical features of meningoencephalitis persisted, along with evidence of varicella zoster virus (VZV) DNA in cerebrospinal fluid (CSF). A satisfactory response to treatment was observed only after the addition of intravenous foscarnet to acyclovir. Based on our experience with this patient, we suggest that in a subset of alloBMT recipients, late dermatomal herpes zoster infections may respond only partially to treatment with standard oral acyclovir. The use of oral acyclovir preparations with higher bioavailability (valacyclovir) or intravenous acyclovir early on may prevent the considerable morbidity associated with disseminated zoster infection. Bone Marrow Transplantation (2000) 26, 795–796.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dumont-Girard F, Roux E, van Lier RA et al. Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants Blood 1998 92: 4464–4471
Hans CS, Miller W, Haake R, Weisdorf D . Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications Bone Marrow Transplant 1994 13: 277–283
Locksley RM, Flournoy N, Sullivan KM, Meyers JD . Infection with varicella-zoster after marrow transplantation J Infect Dis 1985 152: 1172–1181
Peterlund NA, Esmann V, Ipsen J et al. Oral and intravenous acyclovir are equally effective in herpes zoster J Antimicrob Chemother 1984 14: 185–189
Ljungman P, Lonnqvist B, Ringdom O et al. A randomised trial of oral vs intravenous acyclovir for treatment of herpes zoster in bone marrow transplant recipients Bone Marrow Transplant 1989 4: 613–615
de Miranda P, Blum MR . Pharmacokinetics of acyclovir after intravenous and oral administration J Antimicrob Chemother 1983 12: (Suppl. B) 29–37
Oshry T, Lifshitz T . Intravenous acyclovir treatment for extensive herpetic keratitis in a live transplant patient Int Ophthalomol 1997 27: 265–268
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tauro, S., Toh, V., Osman, H. et al. Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an alloBMT patient. Bone Marrow Transplant 26, 795–796 (2000). https://doi.org/10.1038/sj.bmt.1702599
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702599
Keywords
This article is cited by
-
Opportunistic Infections of the Central Nervous System in the Transplant Patient
Current Neurology and Neuroscience Reports (2013)
-
West Nile virus encephalitis causing fatal CNS toxicity after hematopoietic stem cell transplantation
Bone Marrow Transplantation (2004)